TITLE

Start from scratch

AUTHOR(S)
Kondro, Wayne
PUB. DATE
October 2011
SOURCE
CMAJ: Canadian Medical Association Journal;10/4/2011, Vol. 183 Issue 14, pE1051
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that the U.S. Institute of Medicine argues that the machinery of the U.S. Food and Drug Administration's process for regulating moderate risk medical devices completely fails to examine the efficacy and safety of the devices before they are put on the market.
ACCESSION #
66711968

 

Related Articles

  • FDA says device process should remain. Arnold, Matthew // Medical Marketing & Media;Sep2011, Vol. 46 Issue 9, p14 

    The article reports on the stand of the U.S. Food and Drug Administration (FDA) on their approval process for medical devices. It relates that despite of the call by the Institute of Medicine (IOM) to scrap the process of approving many of medical devices, FDA is firmed that the process should...

  • IOM Report Urges FDA to Scrap 510(k) Process. Sprovieri, John // Assembly;Sep2011, Vol. 54 Issue 9, p14 

    The article discusses a report that urges the U.S. Food and Drug Administration (FDA) to develop a new regulatory framework to replace the 510 (k) clearance process for moderate-risk medical devices. The report issued by the Institute of Medicine, a nonprofit advisory organization, claims that...

  • Time to Scrap the U.S. System of Medical Device Regulation? Wiederhold, Brenda K. // CyberPsychology, Behavior & Social Networking;Mar2012, Vol. 15 Issue 3, p127 

    The author reflects on a report of a U.S. Institute of Medicine (IOM) panel on the abandonment of the U.S. Food and Drug Administration (FDA) on its 35-year-old process of clearing medical device. She states that the process is inadequate for patient's protection and that FDA is slow in the...

  • Report finds FDA oversight lacking on pediatric devices.  // Materials Management in Health Care;Sep2005, Vol. 14 Issue 9, p12 

    Reports on the findings of the study conducted by the Institute of Medicine (IOM), a nonprofit institution, which addresses the efficiency of the U.S. Food and Drug Administration (FDA). Comments of IOM on the administration's lack of effective procedures to monitor post-market safety studies of...

  • Paulsen 'shocked' at IOM recommendation. McCarty, Mark // Medical Device Daily;8/1/2011, Vol. 15 Issue 142, p4 

    The article discusses the reaction of Republican Representative Erik Paulsen of Minnesota to the recommendation of the Institute of Medicine (IOM) to eliminate the 510(k) program in the U.S. According to Paulsen, he was shocked at the recommendation and IOM lacks proposals as to how to solve...

  • Suggested device approval revamp gets shrug from FDA. Arnold, Matthew // McKnight's Long-Term Care News;Sep2011, Vol. 32 Issue 9, p32 

    The article reports on the call of the Institute of Medicine (IOM) to the Food and Drug Administration (FDA) to scrap the approval process used for many medical devices because their efficacy or safety is not assessed in the U.S.

  • FDA directs IOM to examine old 510(k) process.  // Biomedical Business & Technology;Nov2009, Vol. 32 Issue 11, p25 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to commission the Institute of Medicine to study the 501(k) process. The DFA review process for medical devices involves premarket approval and the 510(k) process. There have been accusations that products have...

  • Industry Leaders Choose Sides Over IOM's 510(k) Report.  // Medical Product Outsourcing;Sep2011, Vol. 9 Issue 7, p20 

    The article offers news briefs related to medical device industry in the U.S. The Institute of Medicine (IOM) and Food and Drug Administration (FDA) are opposing the 510(k) report to revamp the medical device clearance process. The FDA informs medical device firms that it is cutting user fees by...

  • IOM recommendations seen as too speculative to gain traction. McCARTY, MARK // Medical Device Daily;8/1/2011, Vol. 15 Issue 142, p1 

    The article focuses on recommendations developed by the U.S. Institute of Medicine (IOM) for the 510(k) program at the U.S. Food and Drug Administration (FDA) in the medical device industry. IOM recommends FDA to eliminate the program and start over, but the FDA has no intent to pursue such a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics